Geisinger And Celera To Collaborate On Liver Disease Test
Geisinger Health System and Celera (NYSE:CRA), an Applera Corporation business, has announced that they have entered into a research collaboration with the aim of developing a diagnostic assay for the increased risk of non-alcoholic steatohepatitis (NASH).
More: continued here
Filed under: Liver Disease / Hepatitis on February 26th, 2008